Sorrento Therapeutics, Inc. - 10 Nov 2022 Form 3 Insider Report for Vickers Vantage Corp. I (SCLX)

Role
10%+ Owner
Signature
/s/ Jaisim Shah, Attorney-in-Fact
Issuer symbol
SCLX
Transactions as of
10 Nov 2022
Net transactions value
$0
Form type
3
Filing time
15 Nov 2022, 17:27:26 UTC
Previous filing
23 Jul 2021
Next filing
22 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SCLX Common Stock 135,726,590 10 Nov 2022 Direct
holding SCLX Series A Preferred Stock 29,057,097 10 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney